Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| BEAM | NASDAQ | Beam Therapeutics Inc. | $23.99 | -1.56% | 1.2M | $2.47B |
| CLDX | NASDAQ | Celldex Therapeutics, Inc. | $36.90 | -3.15% | 1M | $2.46B |
| PGEN | NASDAQ | Precigen, Inc. | $6.85 | +2.54% | 2.1M | $2.44B |
| SUPN | NASDAQ | Supernus Pharmaceuticals, Inc. | $41.64 | -0.12% | 707K | $2.42B |
| VRDN | NASDAQ | Viridian Therapeutics, Inc. | $21.24 | -4.71% | 943K | $2.41B |
| HRMY | NASDAQ | Harmony Biosciences Holdings, Inc. | $41.52 | +1.02% | 973K | $2.4B |
| NAMSW | NASDAQ | NewAmsterdam Pharma Company N.V. | $11.10 | -5.77% | 33 | $2.38B |
| IMNM | NASDAQ | Immunome, Inc. | $24.67 | -1.20% | 693K | $2.36B |
| OCUL | NASDAQ | Ocular Therapeutix, Inc. | $10.49 | -1.22% | 2.6M | $2.3B |
| AXGN | NASDAQ | AxoGen, Inc. | $42.16 | +0.74% | 3.5M | $2.27B |
| TRVI | NASDAQ | Trevi Therapeutics, Inc. | $15.90 | -0.06% | 2M | $2.26B |
| HCM | NASDAQ | HUTCHMED (China) Limited | $12.82 | -2.29% | 83K | $2.24B |
| GPCR | NASDAQ | Structure Therapeutics Inc. | $38.66 | -2.25% | 1.3M | $2.23B |
| ADUS | NASDAQ | Addus HomeCare Corporation | $117.09 | -1.21% | 126K | $2.19B |
| OABIW | NASDAQ | OmniAb, Inc. | $0.34 | +0.03% | 1K | $2.16B |
| SRPT | NASDAQ | Sarepta Therapeutics, Inc. | $20.45 | -0.34% | 1.8M | $2.16B |
| PVLA | NASDAQ | Palvella Therapeutics, Inc. | $150.13 | -0.17% | 163K | $2.15B |
| UFPT | NASDAQ | UFP Technologies, Inc. | $277.89 | +0.18% | 81K | $2.15B |
| SLS | NASDAQ | SELLAS Life Sciences Group, Inc. | $11.55 | -14.42% | 14.6M | $2.15B |
| PGNY | NASDAQ | Progyny, Inc. | $27.35 | +1.00% | 1.1M | $2.14B |
| ADMA | NASDAQ | ADMA Biologics, Inc. | $9.23 | -1.70% | 2.3M | $2.14B |
| XRAY | NASDAQ | DENTSPLY SIRONA Inc. | $10.46 | -0.38% | 3.3M | $2.1B |
| ESTA | NASDAQ | Establishment Labs Holdings Inc. | $70.94 | -0.63% | 282K | $2.09B |
| RAPP | NASDAQ | Rapport Therapeutics, Inc. Common Stock | $43.62 | +0.37% | 252K | $2.09B |
| AUPH | NASDAQ | Aurinia Pharmaceuticals Inc. | $16.10 | -0.06% | 745K | $2.07B |
| BCRX | NASDAQ | BioCryst Pharmaceuticals, Inc. | $8.12 | -2.05% | 3.6M | $2.06B |
| URGN | NASDAQ | UroGen Pharma Ltd. | $42.31 | +0.17% | 676K | $2.06B |
| KOD | NASDAQ | Kodiak Sciences Inc. | $32.89 | +0.06% | 682K | $2.06B |
| GENB | NASDAQ | Generate Biomedicines, Inc. | $15.72 | +2.14% | 666K | $2.02B |
| MESO | NASDAQ | Mesoblast Limited | $15.48 | -0.13% | 180K | $2.01B |
| AGIO | NASDAQ | Agios Pharmaceuticals, Inc. | $33.60 | -0.12% | 750K | $2.01B |
| NKTR | NASDAQ | Nektar Therapeutics | $69.76 | -1.26% | 681K | $2B |
| ZBIO | NASDAQ | Zenas BioPharma, Inc. | $31.12 | +0.06% | 422K | $1.96B |
| VCEL | NASDAQ | Vericel Corporation | $38.34 | +1.24% | 504K | $1.96B |
| CMPS | NASDAQ | COMPASS Pathways plc | $14.35 | +0.91% | 2M | $1.94B |
| ALMR | NASDAQ | Alamar Biosciences, Inc. | $27.89 | +0.43% | 324K | $1.93B |
| ZYME | NASDAQ | Zymeworks Inc. | $26.24 | -0.74% | 575K | $1.93B |
| ASTH | NASDAQ | Astrana Health, Inc. | $37.98 | -0.13% | 192K | $1.88B |
| BRVE | NASDAQ | Braveheart Bio, Inc. | $26.64 | -2.24% | 284K | $1.88B |
| SGRY | NASDAQ | Surgery Partners, Inc. | $14.38 | +1.84% | 1.3M | $1.88B |
| STOK | NASDAQ | Stoke Therapeutics, Inc. | $29.03 | -1.06% | 574K | $1.87B |
| NBTX | NASDAQ | Nanobiotix S.A. | $37.01 | -1.57% | 94K | $1.87B |
| GHRS | NASDAQ | GH Research PLC | $27.20 | -0.29% | 159K | $1.86B |
| LMAT | NASDAQ | LeMaitre Vascular, Inc. | $80.59 | +2.27% | 279K | $1.84B |
| COAG | NASDAQ | Hemab Therapeutics Holdings, Inc. Common Stock | $39.40 | -1.20% | 408K | $1.84B |
| XNCR | NASDAQ | Xencor, Inc. | $24.41 | +0.62% | 905K | $1.81B |
| KLRA | NASDAQ | Kailera Therapeutics, Inc. | $13.94 | -6.51% | 815K | $1.81B |
| NVCR | NASDAQ | Novocure Ltd | $15.51 | +1.04% | 1.1M | $1.81B |
| MRVI | NASDAQ | Maravai LifeSciences Holdings, Inc. | $6.53 | -2.97% | 2.8M | $1.8B |
| VIR | NASDAQ | Vir Biotechnology, Inc. | $10.62 | +0.38% | 2.1M | $1.79B |
50 Healthcare Companies
Review companies currently returned for the Healthcare screen, with price, performance, volume and market-cap context.
How This Sector Screen Works
Results are loaded from current company data and can be narrowed by exchange or company search without changing the canonical sector page.
About the Healthcare Sector
The Healthcare classification groups companies with related business activities so investors can compare peers within a common market segment.
Related Sector Screens
Return to the screener directory to compare this sector with daily movers and the other industry groups covered by Cashu Finance.